학술논문
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type (PLoS Pathogens (2020) 15:12 (E1008121) DOI: 10.1371/journal.ppat.1008121)
Document Type
Erratum
Author
Schifanella, L.; Barnett, S.W.; Bissa, M.; Galli, V.; Doster, M.N.; Vaccari, M.; Tomaras, G.D.; Shen, X.; Phogat, S.; Pal, R.; Montefiori, D.C.; LaBranche, C.C.; Rao, M.; Trinh, H.V.; Washington-Parks, R.; Liyanage, N.P.M.; Gorini, G.; Brown, D.R.; Liang, F.; Loré, K.; Venzon, D.J.; Magnanelli, W.; Metrinko, M.; Kramer, J.; Breed, M.; Alter, G.; Ruprecht, R.M.; Franchini, G.
Source
In: PLoS Pathogens . (PLoS Pathogens, April 2020, 16(4))
Subject
Language
English
ISSN
15537374
15537366
15537366